术前钙与骨化三醇治疗与甲状腺全切除术后低钙血症的关联
这项回顾性队列研究在三级医疗中心纳入65例由单一术者行甲状腺全切除术的患者,比较术前联合术后补充碳酸钙(1000至1500 mg,每日3次)与骨化三醇(0.25至0.5 µg,每日2次)与仅术后补充同剂量药物的差异。结果显示术前补充组有症状性低钙血症发生率、住院时间和总费用均较低。
要点
- 术前补充组有症状性低钙血症2/33(6%),未补充组5/32(16%),绝对差异10%(95% CI,-6.6%至26.3%)。
- 术前补充组平均住院时间3.8(1.8)天 vs 未补充组2.9(1.4)天,绝对差异-0.9天(95% CI,-1.70至-0.105天)。
- 术前补充估计每例甲状腺全切除术患者节省2819美元费用。
核心结论
- 术前联合术后补充钙和骨化三醇与甲状腺全切除术后有症状性低钙血症发生率、住院时间和总费用降低相关。
研究设计与样本
- 回顾性队列研究,在三级医疗中心由单一术者行甲状腺全切除术的65例患者。
- 患者分为两组:术前及术后均补充碳酸钙1000至1500 mg每日3次和骨化三醇0.25至0.5 µg每日2次组(33例),以及仅术后补充同剂量药物组(32例)。
- 数据来自2008年1月1日至2011年12月31日期间手术的患者,数据分析于2012年3月至6月及2016年10月至12月进行。
主要发现
- 65例患者中27例(42%)为男性,平均(SD)年龄49.7(16.7)岁。
- 术前补充组33例中15例(45%)行中央区颈淋巴结清扫,11例(33%)行侧颈淋巴结清扫;未补充组32例中分别为16例(50%)和12例(38%)。
- 未补充组 vs 补充组平均血清钙:术前9.6 vs 9.4 mg/dL(绝对差异0.16;95% CI,-0.12至0.49 mg/dL);术后12小时8.3 vs 8.6 mg/dL(绝对差异-0.30;95% CI,-0.63至0.02 mg/dL);术后24小时8.4 vs 8.5 mg/dL(绝对差异-0.13;95% CI,-0.43至0.16 mg/dL)。
- 未补充组有症状性低钙血症5/32(16%) vs 术前补充组2/33(6%),绝对差异10%(95% CI,-6.6%至26.3%)。
- 术前补充组平均(SD)住院时间较未补充组显著缩短:3.8(1.8) vs 2.9(1.4)天;绝对差异-0.9天(95% CI,-1.70至-0.105天)。
临床怎么用
- 原文结论指出术前钙和骨化三醇补充联合常规术后补充与有症状性低钙血症发生率、住院时间和总费用降低相关。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Hypocalcemia is the most common complication after total thyroidectomy and can result in prolonged hospital admissions and increased hospital charges. OBJECTIVE: To determine the effectiveness of preoperative calcium and calcitriol supplementation in reducing hypocalcemia following total thyroidectomy. DESIGN, SETTING, AND PARTICIPANTS: A retrospective cohort study was conducted at a tertiary care center in 65 patients undergoing total thyroidectomy by a single surgeon. Patients were divided into 2 groups: those receiving preoperative as well as postoperative supplementation with calcium carbonate, 1000 to 1500 mg, 3 times daily and calcitriol, 0.25 to 0.5 µg, twice daily, and those receiving only postoperative supplementation with those agents at the same dosages. Data on patients who underwent surgery between January 1, 2008, and December 31, 2011, were acquired, and data analyses were conducted from March through June 2012, and from October through December 2016. INTERVENTIONS: Calcium and calcitriol therapy. MAIN OUTCOMES AND MEASURES: Postoperative serum calcium levels and development of postoperative hypocalcemia. RESULTS: Of the 65 patients who underwent total thyroidectomy 27 (42%) were men; mean (SD) age was 49.7 (16.7) years. Thirty-three patients received preoperative calcium and calcitriol supplementation, and 32 patients received only postoperative therapy. In the preoperative supplementation group, 15 of 33 (45%) patients underwent complete central compartment neck dissection and 11 of 33 (33%) had lateral neck dissection, compared with 16 of 32 (50%) and 12 of 32 (38%), respectively, patients without preoperative supplementation. The mean measured serum calcium level in those without preoperative supplementation vs those with supplementation are as follows: preoperative, 9.6 vs 9.4 mg/dL (absolute difference, 0.16; 95% CI, -0.12 to 0.49 mg/dL); 12 hours postoperative, 8.3 vs 8.6 mg/dL (absolute difference, -0.30; 95% CI, -0.63 to 0.02 mg/dL); and 24 hours postoperative, 8.4 vs 8.5 mg/dL (absolute difference, -0.13; 95% CI, -0.43 to 0.16 mg/dL). In patients not receiving preoperative supplementation, 5 of 32 (16%) individuals became symptomatically hypocalcemic vs 2 of 33 (6%) in the preoperative supplementation group; an absolute difference of 10% (95% CI, -6.6% to 26.3%). Compared with the group not receiving preoperative supplementation, the mean [SD] length of stay was significantly shorter in the preoperative supplementation group (3.8 [1.8] vs 2.9 [1.4] days; absolute difference, -0.9; 95% CI, -1.70 to -0.105 days). Preoperative supplementation resulted in an estimated $2819 savings in charges per patient undergoing total thyroidectomy. CONCLUSIONS AND RELEVANCE: Preoperative calcium and calcitriol supplementation, in addition to routine postoperative supplementation, was associated with a reduced incidence of symptomatic hypocalcemia, length of hospital stay, and overall charges following total thyroidectomy.
引用
- Maxwell AK, Shonka DC, Robinson DJ, et al. Association of Preoperative Calcium and Calcitriol Therapy With Postoperative Hypocalcemia After Total Thyroidectomy. JAMA Otolaryngol Head Neck Surg. 2017. PMID: 28418509. doi:10.1001/jamaoto.2016.4796
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。